Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-01-29 @ 7:34 PM
Study NCT ID:
NCT00857467
Status:
COMPLETED
Last Update Posted:
2009-12-23
First Post:
2009-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.
Sponsor:
Norgine
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NRL001-01/2008 (SUM)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Vice President Clinical Development
Old Organization:
Norgine